FOLH1 and prostate cancer: As a new radioactive tracer of PET/CT, 68GA-labeled PSMA ligand had good sensitivity and specificity in detecting primary prostate cancer, and showed superior diagnostic performance in both pooled as well as subgroup analysis estimates.